Unifying the Treatment Community

National Methadone Conference AMTA 2001

Sunday, October 7th


Pre-conference Meeting

This special pre-conference meeting is divided into two sessions – a morning and afternoon session. These sessions have been developed by the Advocacy Coalition: National Alliance of Methadone Advocates (NAMA), Advocates for Recovery through Medicine (ARM), Advocates For the Integration of Recovery and Methadone (AFIRM), Virginia Alliance of Methadone Advocates (VAMA), and Addiction Treatment Watchdog, and are designed to take the combined knowledge and experience of the advocacy community and present concepts that will assist in the understanding of medication assisted treatments like methadone and LAAM, as well as the new regulations (42 CRF Part 8) and accreditation, from both the patient’s and the staff’s perspective. Audiences for these sessions include patients, counselors, medical and administrative personnel, advocates and all others involved in the field of opioid agonist treatment.

8:30 A.M. to 12 Noon Session: Accreditation, Networking and Skill Building

Nuts and Bolts of Regulations/Accreditation
Presenter: C. Todd Rosendale, CSAT/OPAT

Group Discussion on Advocacy
Moderator: Joycelyn Woods, NAMA

Networking & How Best to Utilize Time and Skills at a Conference
Presenters: Joycelyn Woods & Jo Sotheran, NAMA

1 P.M. to 5 P.M. Session: The Vision Of The Future

The Graying of Methadone Maintnenace Treatment
Presenter: C. Todd Rosendale, CSAT/OPAT

Making Accreditation Work For You: a How-To for Patients and Programs
Presenter: Joycelyn Woods, NAMA

Warm and Fuzzy With the Community
Presenter: Fred Christie, AFIRM

How to Start an Advocacy Group
Presenter: James DePasquale, NAMA

Methadone Works; Medical Efficacy From the Patient’s Perspective
Presenter: Sean P. Murphy

Pictures

Howard is Ready

Howard is Ready!

Howard Lotsof, Acting Membership Director and member of NAMA’s Board prepares for the preconference day.

Jo Presents

Jo Makes a Point

Jo Presents.

Jo Sotheran, Treasurer and member of NAMA’s board talks about the importance of planning at a conference.

Jo Makes a Point and shows the advocates how to use a conference program to set goals for a conference.

Donna Schoen helps James DePasquale.

Donna Schoen (LIJ Patient Committee) helps James DePasquale, former Membership Director talk about starting an advocacy group.

Operations and Oversight!

Operations and Oversight

Jo Sotheran talks methadone politics and patient rights with Joycelyn S. Woods, NAMA’s President

Sponsored by the Center for Substance Abuse Treatment


Return to AMTA 2001 Index

Similar Posts

  • About Webrings

    Admin 06/24/2022

    What is a Webring? A Webring is a group of sites linked together usually around a specific topic. The purpose is to give surfers access to information about the topic that the Webring is organized around. For Example: A Webring could be organized around Little League. Some websites could belong to the various leagues and…

  • NAMA Talk

    Admin 02/07/2022

    Volumn 2, Number 1 February 15, 2000 Organizational News by Joycelyn Woods The big news as this year and the Millennium closes is that methadone is slowly moving to being an accepted medical treatment. This is only the beginning THE FIRST STEP – and there is still an immense amount of work to be done….

  • |

    Internet Resources

    Admin 05/29/2021

    Treatment Facility Locator Buprenorphine Physician Locator Maintenance Assistance Point (Europe) Indro’s Coordinating and Information Resource Center for International Travel Traveler’s Health Kit Office of National Drug Control Policy Center For Substance Abuse Treatment CSAT Patient Support & Community Education Project Program Version (PDF Format) National Clearinghouse Opioid Drugs in Maintenance and Detoxification Treatment of Opiate…

  • Methadone Take Home Bottle Recall

    Admin 02/17/2023

    The intent of Bottle Recall initially was to be able to allow patients take home medication and to insure that methadone is not diverted to the streets. However, methadone programs have been giving patients take home medication for years without a serious methadone diversion problem. Furthermore numerous studies have demonstrated that methadone is not a…

  • Focus On

    Admin 09/16/2021

    Issues To Focus On LAAM Manufacture to Be Discontinued August 23, 2003 Washington, D.C. Roxanne the manufacturer of LAAM has informed the FDA that manufacture of the medication is being discontinued. Distribution will continue until the inventory is depleted. Roxanne estimates this to be in early January 2004. The reason for the action is the…